Evidence map›Paper›PMID 36422479›Full record

ReviewTurkish journal of medical sciences2022

Microglial iron trafficking: new player in brain injury.

Elif Keleş, Hasan Hüseyin Kazan, Arzu Aral, Hayrunnisa Bolay

Open access · bronzeAbstract readReview
In one paragraph

Review in Turkish journal of medical sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Elif KeleşNeuropsychiatry of Education, Research and Application Center, Faculty of Medicine, Gazi University, Ankara, Turkey ; Department of Radiology, Feinberg School of Medicine, Northwestern University, Chicago, USA.
Hasan Hüseyin KazanDepartment of Medical Genetics, Faculty of Medicine, Gazi University, Ankara, Turkey.
Arzu AralNeuroscience and Neurotechnology Center of Excellence (NÖROM), Ankara, Turkey ; Department of Immunology, Faculty of Medicine, İzmir Demokrasi University, İzmir, Turkey.
Hayrunnisa BolayNeuropsychiatry of Education, Research and Application Center, Faculty of Medicine, Gazi University, Ankara, Turkey ; Neuroscience and Neurotechnology Center of Excellence (NÖROM), Ankara, Turkey.
Society for Neuroscience · USGazi University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNeonatal brain injury is a significant reason of neurodevelopmental abnormalities and long-term neurological impairments. Hypoxic-ischemic encephalopathy and preterm brain injury, including intraventricular hemorrhage are the most common grounds of brain injury for full-term and preterm neonates. The prevalence of hypoxic ischemic encephalopathy varies globally, ranging from 1 to 3.5/1000 live births in high-resource countries and 26/1000 in low-resource countries. Preterm birth's global incidence is 15 million, a significant reason for infant mortality and morbidity, permanent neurologic problems, and the associated social and economic burden. The widespread neurodevelopmental effects of neonatal brain injury could have an unfavorable impact on a variety of aspects of cognitive, linguistic, behavioral, sensory, and motor functions. Brain injury occurs via various mechanisms, including energy deprivation, excitatory amino acids, mitochondrial dysfunction, reactive oxygen species, and inflammation giving rise to different forms of cell death. The contribution of microglial activity in neonatal brain injury has widely been underlined by focusing on cell death mechanisms since the neuronal death pathways during their development are distinct from those in the adult brain. Iron accumulation and lipid peroxidation cause a relatively novel type of regulated cell death called ferroptosis. Neonates generally have biochemical iron inequalities, and their antioxidant potential is highly restricted, implying that ferroptosis may be significant in pathologic conditions. Moreover, inhaled nitric oxide therapy in infants may lead to microglial inflammation via ferroptosis and neuronal injury in the developing brain. This review article aims to summarize the studies that investigated the association between neonatal brain injury and iron metabolism, with a particular emphasis on the microglial activity and its application to the inhibition of neonatal brain injury.

Indexed as

Brain InjuriesHypoxia-Ischemia, BrainPremature BirthFemaleHumansInfantInfant, NewbornInflammationIronMicrogliaIronbrain injury in neonatesferroptosisipid peroxidationiron metabolismmicrogliaNeonatal brain development

Identifiers

PMID36422479
PMCPMC10395700
OpenAlexW4310335759

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.